Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
None
Evaluation of Safety and Efficacy of IBI318 Monotherapy for Relapsed/Refractory Extranodal NK/T Cell Lymphoma (Nasal Type) Trial

The purpose of this study is to evaluate the safety and efficacy of IBI318 monotherapy for relapsed/refractory extranodal NK/T cell lymphoma (nasal type).

  • 0 views
  • 28 Jan, 2021
  • 1 location
None
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma Nasal Type

This is a phase 2, Open-label, to investigate the efficacy and safety of IMC-001 in patients with Relapsed or Refractory extranodal NK/T cell lymphoma, nasal type

renal function
  • 0 views
  • 26 Jan, 2021
  • 1 location
None
Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL

low-risk extranodal NK/T cell lymphoma, nasal type

  • 0 views
  • 19 Dec, 2021
  • 1 location